NCT05643352

Brief Summary

The aim of the study is to determine whether there is a statistically significant difference in snoring intensity before and after performing a Barbed Reposition Pharyngoplasty as a single-level snoring procedure. The investigators aim to determine whether this is a valid alternative to the more classical techniques of pharyngoplasty. Furthermore, the investigators also wish to map the various postoperative complications and compare them with those of the more conventional techniques. The investigators compare the snoring intensity before surgery with the snoring intensity at 2 weeks (first postoperative control), at 6 weeks (second postoperative control) and at 6 months (Third postoperative control). For the evaluation of snoring, the investigators use 4 scales/questionnaires. These questionnaires are currently also used as standard at the outpatient clinic for snoring problems. These 4 scales/questionnaires are completed at every check-up. During the first postoperative check-up, the postoperative side effects are checked (bleeding, infection, readmission, needed consultation with another doctor, date of resumption of work). The investigators also map the pain with a visual analog scale and measure this the day after the operation and let the patient fill it in 3 days, 1 week and 2 weeks after the operation.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
16

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Oct 2022

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

October 1, 2022

Completed
2 months until next milestone

First Submitted

Initial submission to the registry

November 23, 2022

Completed
8 days until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2022

Completed
7 days until next milestone

First Posted

Study publicly available on registry

December 8, 2022

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

February 1, 2023

Completed
Last Updated

December 8, 2022

Status Verified

December 1, 2022

Enrollment Period

2 months

First QC Date

November 23, 2022

Last Update Submit

December 7, 2022

Conditions

Keywords

PharyngoplastyBarbed reposition pharyngoplastySnoringSurgery

Outcome Measures

Primary Outcomes (3)

  • Change in Snoring intensity

    Seld-reported subjective score from 0 to 10 that describes the impact of snoring with 0 meaning no snoring and 10 meaning sleeping separately from partner

    At 2 weeks, at 6 weeks and at 6 months

  • Change in Snoring severity

    Seld-reported subjective score that describes the severity of snoring (frequency, duration,...). Score from 0 to 9 with 0 meaning never snoring and 9 meaning snoring every night during the entire night with sounds audible from another floor

    At 2 weeks, at 6 weeks and at 6 months

  • Change in Snoring score

    Seld-reported subjective score that describes the overall loudness of snoring with score of 0 meaning no snoring and 10 meaning extreme snoring

    At 2 weeks, at 6 weeks and at 6 months

Secondary Outcomes (1)

  • Change in Epworth Sleepiness Scale

    At 2 weeks, at 6 weeks and at 6 months

Interventions

Barbed reposition pharyngoplasty was performed in all patients

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • single-level retro-palatal collapse observed during drug-induced sleep endoscopy (DISE)

You may not qualify if:

  • OSAS defined as having an obstructive AHI (OAHI) ≥ 30
  • Obese patients with a body mass index (BMI) ≥ 30 kg/m².
  • Patients with multilevel airway collapse observed during DISE
  • Patients younger than 18 years old.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Neus-, keel- en oorziekten, gelaats- en halschirurgie AZ Delta

Roeselare, 8800, Belgium

Location

MeSH Terms

Conditions

SnoringSleep Apnea Syndromes

Condition Hierarchy (Ancestors)

Respiratory SoundsSigns and Symptoms, RespiratorySigns and SymptomsPathological Conditions, Signs and SymptomsApneaRespiration DisordersRespiratory Tract DiseasesSleep Disorders, IntrinsicDyssomniasSleep Wake DisordersNervous System Diseases

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

November 23, 2022

First Posted

December 8, 2022

Study Start

October 1, 2022

Primary Completion

December 1, 2022

Study Completion

February 1, 2023

Last Updated

December 8, 2022

Record last verified: 2022-12

Data Sharing

IPD Sharing
Will not share

Locations